Clorox (NYSE:CLX) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of The Clorox Company (NYSE:CLX). In a filing disclosed on January 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Clorox stock on December 19th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 12/30/2025.
  • Sold $1,001 – $15,000 in shares of Schneider Electric S.E. (OTCMKTS:SBGSF) on 12/30/2025.
  • Sold $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 12/30/2025.
  • Purchased $50,001 – $100,000 in shares of Campbell’s (NASDAQ:CPB) on 12/30/2025.
  • Sold $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 12/30/2025.
  • Sold $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 12/26/2025.
  • Sold $1,001 – $15,000 in shares of Bloom Energy (NYSE:BE) on 12/24/2025.
  • Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 12/24/2025.
  • Sold $1,001 – $15,000 in shares of Coinbase Global (NASDAQ:COIN) on 12/24/2025.
  • Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 12/24/2025.

Clorox Trading Up 2.3%

NYSE CLX traded up $2.49 on Wednesday, reaching $111.35. 2,152,065 shares of the company were exchanged, compared to its average volume of 2,297,796. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. The business’s fifty day moving average price is $102.93 and its 200 day moving average price is $115.45. The stock has a market capitalization of $13.58 billion, a P/E ratio of 17.48, a price-to-earnings-growth ratio of 0.53 and a beta of 0.58. The Clorox Company has a fifty-two week low of $96.66 and a fifty-two week high of $164.22.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same period last year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 4.5%. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Nomura Asset Management Co. Ltd. raised its holdings in shares of Clorox by 9.0% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after purchasing an additional 27,639 shares during the period. Simplicity Wealth LLC grew its holdings in shares of Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares during the period. Hudson Bay Capital Management LP acquired a new stake in Clorox during the 2nd quarter worth approximately $8,568,000. Vise Technologies Inc. purchased a new position in shares of Clorox in the 2nd quarter valued at $328,000. Finally, Brookstone Capital Management lifted its holdings in shares of Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after acquiring an additional 88,024 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Barclays decreased their price objective on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a report on Tuesday, November 4th. Citigroup lowered their price target on Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a report on Wednesday, December 17th. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. TD Cowen decreased their target price on shares of Clorox from $117.00 to $108.00 and set a “hold” rating on the stock in a research report on Thursday, January 8th. Finally, Wells Fargo & Company dropped their price target on shares of Clorox from $117.00 to $108.00 and set an “equal weight” rating for the company in a research report on Monday, January 5th. One analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $122.63.

Get Our Latest Research Report on Clorox

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Clorox Company Profile

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.